Skip to main navigation Skip to search Skip to main content

Second-generation antipsychotic-induced hypoglycemia

  • Tomonari Fujita
  • , Yoshito Mizoguchi
  • , Yutaka Kunitake
  • , Hiroshi Tateishi
  • , Takayoshi Inaba
  • , Takahiro A. Kato
  • , Akira Monji

Research output: Contribution to journalArticlepeer-review

Abstract

Complaints of hypoglycemia resemble the sedative effect of antipsychotics. As such, clinicians may overlook hypoglycemia in patients with psychiatric disorders. Here, a case of hypoglycemia associated with hyperinsulinemia induced by quetiapine in a female patient with bipolar disorder is reported. The case suggests that clinicians should be aware of the potential for hypoglycemia induced by second-generation antipsychotics.

Original languageEnglish
Article number17br02186
JournalPrimary Care Companion to the Journal of Clinical Psychiatry
Volume20
Issue number1
DOIs
Publication statusPublished - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Second-generation antipsychotic-induced hypoglycemia'. Together they form a unique fingerprint.

Cite this